Flagship Harbor Advisors, LLC Repligen Corp Transaction History

Flagship Harbor Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 08, 2021	SELL	$148.08 - $206.57 $80,555 - $112,374	-544 Closed	0 $0
Q3 2020 Oct 13, 2020	BUY	$122.51 - $158.27 $2,205 - $2,848	18 Added 3.42%	544 $80,000
Q2 2020 Jul 31, 2020	BUY	$94.33 - $140.48 $14,149 - $21,072	150 Added 39.89%	526 $65,000
Q3 2019 Oct 22, 2019	BUY	$76.65 - $95.51 $8,431 - $10,506	110 Added 41.35%	376 $28,000
Q2 2019 Jul 22, 2019	BUY	$54.2 - $85.95 $3,577 - $5,672	66 Added 33.0%	266 $22,000
Q2 2018 Aug 14, 2018	BUY	$35.26 - $47.04 $7,052 - $9,408	200 New	200 $9,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.02B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Flagship Harbor Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Flagship Harbor Advisors, LLC with notifications on news.